Murine hepatic p53, RB, and CDK inhibitory protein expression following acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure (Q73305418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Murine hepatic p53, RB, and CDK inhibitory protein expression following acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J A Rininger

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D A Stoffregen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J G Babish

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

5-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1557-1568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

The Ah receptor and the mechanism of dioxin toxicity

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Characterization of multiple forms of the Ah receptor: comparison of species and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals?

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Protein tyrosine phosphorylations as an indicator of 2,3,7,8-tetrachloro-p-dioxin exposure in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Growth stimulation of primary rat hepatocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Tumor-promoting effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital in initiated weanling Sprague-Dawley rats: a quantitative, phenotypic, and ras p21 protein study

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Cell-cycle regulators and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Animal cell cycles and their control

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Cell cycle control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0045-6535%2896%2900451-1

7 January 2021

10.1016/S0045-6535(96)00451-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134687%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference